Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists

Uveitis Specialists Study Group

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose: To assess the approach of specialists to ocular tuberculosis (TB). Methods: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. Results: Of 196 members, 87 responded (44.4%), of whom 64 were affiliated with practices in North America, while 23 were outside of North America. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on such issues as (1) the pretest probability that a patient with granulomatous panuveitis had TB uveitis (range 1-75%) or that a patient with a risk factor for TB had ocular TB (range 0-90%); (2) the optimal duration of anti-TB therapy; and (3) whether therapy should be discontinued after 2 months in nonresponders. Conclusions: Consensus is lacking among uveitis specialists for the diagnosis or management of ocular TB.

Original languageEnglish (US)
Pages (from-to)25-31
Number of pages7
JournalOcular Immunology and Inflammation
Volume23
Issue number1
DOIs
StatePublished - Feb 1 2015

Fingerprint

Ocular Tuberculosis
Uveitis
Tuberculosis
North America
Panuveitis
Therapeutics
Physicians

Keywords

  • Post-test probability
  • Pretest probability
  • Tuberculosis
  • Uveitis

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. / Uveitis Specialists Study Group.

In: Ocular Immunology and Inflammation, Vol. 23, No. 1, 01.02.2015, p. 25-31.

Research output: Contribution to journalArticle

@article{47b04dc9b2ef450eb2af030174ba5e12,
title = "Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists",
abstract = "Purpose: To assess the approach of specialists to ocular tuberculosis (TB). Methods: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. Results: Of 196 members, 87 responded (44.4{\%}), of whom 64 were affiliated with practices in North America, while 23 were outside of North America. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on such issues as (1) the pretest probability that a patient with granulomatous panuveitis had TB uveitis (range 1-75{\%}) or that a patient with a risk factor for TB had ocular TB (range 0-90{\%}); (2) the optimal duration of anti-TB therapy; and (3) whether therapy should be discontinued after 2 months in nonresponders. Conclusions: Consensus is lacking among uveitis specialists for the diagnosis or management of ocular TB.",
keywords = "Post-test probability, Pretest probability, Tuberculosis, Uveitis",
author = "{Uveitis Specialists Study Group} and Lou, {Susan M.} and Larkin, {Kelly L.} and Kevin Winthrop and Rosenbaum, {James (Jim)} and Massimo Accorinti and Sofia Androudi and Lourdes Arellanes and Matthias Becker and Bahram Bodaghi and Chee, {Soon Phaik} and {De Smet}, Smet and D. Marc and Michal Kramer and Genevieve Larkin and Sue Lightman and Lyndell Lim and Juan Lopez and Friederike Mackensen and Peter McCluskey and Cristina Muccioli and {Okada Annabelle}, A. and Narciss Okhravi and Daniel Vasconcelos-Santos and Zamir, {Peter McCluskey} and Manfred Zierhut and Nisha Acharya and Andrea Birnbaum and Butler, {Nicholas J.} and David Callanan and Emmett Cunningham and Sam Dahr and Davis, {Janet L.} and Larissa Derzko-Dzulynsky and James Dunn and Edwards, {Albert O.} and Lisa Faia and Naomi Falk and Farzin Forooghian and Foster, {C. Stephen} and Friedman, {Alan H.} and Sunir Garg and Paul Gaudio and Ronald Gentile and Debra Goldstein and Douglas Jabs and Glen Jaffe and Kashyap Kansupada and Henry Kaplan and Thomas Hwang and Eric Suhler",
year = "2015",
month = "2",
day = "1",
doi = "10.3109/09273948.2014.926936",
language = "English (US)",
volume = "23",
pages = "25--31",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists

AU - Uveitis Specialists Study Group

AU - Lou, Susan M.

AU - Larkin, Kelly L.

AU - Winthrop, Kevin

AU - Rosenbaum, James (Jim)

AU - Accorinti, Massimo

AU - Androudi, Sofia

AU - Arellanes, Lourdes

AU - Becker, Matthias

AU - Bodaghi, Bahram

AU - Chee, Soon Phaik

AU - De Smet, Smet

AU - Marc, D.

AU - Kramer, Michal

AU - Larkin, Genevieve

AU - Lightman, Sue

AU - Lim, Lyndell

AU - Lopez, Juan

AU - Mackensen, Friederike

AU - McCluskey, Peter

AU - Muccioli, Cristina

AU - Okada Annabelle, A.

AU - Okhravi, Narciss

AU - Vasconcelos-Santos, Daniel

AU - Zamir, Peter McCluskey

AU - Zierhut, Manfred

AU - Acharya, Nisha

AU - Birnbaum, Andrea

AU - Butler, Nicholas J.

AU - Callanan, David

AU - Cunningham, Emmett

AU - Dahr, Sam

AU - Davis, Janet L.

AU - Derzko-Dzulynsky, Larissa

AU - Dunn, James

AU - Edwards, Albert O.

AU - Faia, Lisa

AU - Falk, Naomi

AU - Forooghian, Farzin

AU - Foster, C. Stephen

AU - Friedman, Alan H.

AU - Garg, Sunir

AU - Gaudio, Paul

AU - Gentile, Ronald

AU - Goldstein, Debra

AU - Jabs, Douglas

AU - Jaffe, Glen

AU - Kansupada, Kashyap

AU - Kaplan, Henry

AU - Hwang, Thomas

AU - Suhler, Eric

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Purpose: To assess the approach of specialists to ocular tuberculosis (TB). Methods: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. Results: Of 196 members, 87 responded (44.4%), of whom 64 were affiliated with practices in North America, while 23 were outside of North America. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on such issues as (1) the pretest probability that a patient with granulomatous panuveitis had TB uveitis (range 1-75%) or that a patient with a risk factor for TB had ocular TB (range 0-90%); (2) the optimal duration of anti-TB therapy; and (3) whether therapy should be discontinued after 2 months in nonresponders. Conclusions: Consensus is lacking among uveitis specialists for the diagnosis or management of ocular TB.

AB - Purpose: To assess the approach of specialists to ocular tuberculosis (TB). Methods: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. Results: Of 196 members, 87 responded (44.4%), of whom 64 were affiliated with practices in North America, while 23 were outside of North America. The survey provided normative data on how physicians evaluate patients with uveitis as well as opinions about ocular TB. Responses varied widely on such issues as (1) the pretest probability that a patient with granulomatous panuveitis had TB uveitis (range 1-75%) or that a patient with a risk factor for TB had ocular TB (range 0-90%); (2) the optimal duration of anti-TB therapy; and (3) whether therapy should be discontinued after 2 months in nonresponders. Conclusions: Consensus is lacking among uveitis specialists for the diagnosis or management of ocular TB.

KW - Post-test probability

KW - Pretest probability

KW - Tuberculosis

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=84921709676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921709676&partnerID=8YFLogxK

U2 - 10.3109/09273948.2014.926936

DO - 10.3109/09273948.2014.926936

M3 - Article

C2 - 25019973

AN - SCOPUS:84921709676

VL - 23

SP - 25

EP - 31

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 1

ER -